By reducing staff and access to treatment, the suspension of USAID and other funding threatens the country’s progress in HIV ...

Andy started a part-time faculty position teaching courses in Electronics Engineering Technology and is concerned that ...

Alkermes plc (Nasdaq: ALKS) ("Alkermes") and Avadel Pharmaceuticals plc (Nasdaq: AVDL) ("Avadel") today announced that the companies have entered into a definitive agreement under which Alkermes will ...

Laughing Water Capital shares Q3 insights on portfolio drawdowns, long-term value bets, and thesis-confirming signals. Read ...

CorMedix acquires Melinta, diversifies products, and raises 2025 revenue outlook to $375M. Read here for more details on CRMD ...

The FDA is requiring updated labeling for tranexamic acid injection to emphasize the risk of serious harm, including death, if administered incorrectly via spinal injection. Tranexamic acid injection ...

When machine learning is used to suggest new potential scientific insights or directions, algorithms sometimes offer ...

What is the ‘golden dose’ and what are the risks? Medical News Today asks four experts to weigh in on the trend of trying to ...

Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced new real-world preliminary data from the OPTION-VMS Phase IV, longitudinal, observational study, ...

A prospective study conducted at Avicenna University Hospital (Cadi Ayyad University) suggests that the plethysmographic ...

Subscription and guarantee commitments totaling €5.9 million, representing 75.5% of the envisaged capital increase Subscription price: €1.80 per share, representing a 29.4% discount to the closing ...

FDA-Registered Home Laser Technology Gains Rapid Adoption During Winter Season as Year-End HSA/FSA Deadlines Drive 290% Search Surge-Podiatrists Report Clinical-Grade Results Without $2,500+ Professio ...